{"abstract": "Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion offer by Japan\u2019s Daiichi Sankyo for the Indian generic drug maker, the Business Standard newspaper said.", "web_url": "https://dealbook.nytimes.com/2008/06/13/pfizer-may-table-counter-bid-for-indias-ranbaxy-report-says/", "snippet": "", "lead_paragraph": "Pfizer may bid for Ranbaxy Laboratories, countering a $4.6 billion offer by Japan\u2019s Daiichi Sankyo for the Indian generic drug maker, the Business Standard newspaper said.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer May Table Counter-Bid for India\u2019s Ranbaxy, Report Says", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-06-13T10:59:18+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/3e325273-4183-5548-a4da-f638438a1578", "word_count": 191, "uri": "nyt://article/3e325273-4183-5548-a4da-f638438a1578"}